Structure Therapeutics (GPCR) PT Raised to $120 at Morgan Stanley
Tweet
Share
E-mailGet Alerts GPCR Hot Sheet
Price: $54.51 -0.35%
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn raised the price target on Structure Therapeutics (NASDAQ: GPCR) to $120.00 (from $118.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Diversified Royalty Corp (DIV:CN) (BEVFF) PT Lowered to Cdn$4.75 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
